S Chua1, S Mei Liu, Q Li, L Yang, V T Thassanapaff, P Fisher. 1. Division of Molecular Genetics and New York Obesity Research Center, Department of Pediatrics, Columbia University, New York, USA. sc569@columbia.edu
Abstract
AIMS: Our goal was to identify genetic variants that determine the response to insulin resistance and hyperglycaemia. This report documents the diabetes syndrome of two new congenic strains of mice generated by the transfer of the Lepr(db) mutation to the FVB/NJ strain and the Lep(ob) mutation to the DBA/2J strain. METHODS: Mice were characterised by measures of blood metabolites and hormones along with challenges with glucose and insulin injections. Histological examinations of the endocrine pancreas and the kidneys were also carried out. RESULTS: Obese mice of the FVB-db congenic strain show long-term hyperglycaemia that is primarily due to severe insulin resistance. The hyperglycaemia in the fed state persists despite escalating secretion of insulin and massive increase of pancreatic beta cells. Obese FVB-db mice show evidence of mesangial matrix expansion, a hallmark of diabetic nephropathy. Leptin-deficient mice of the DBA-ob strain have variable obesity-diabetes. In mice with high insulin (>10 ng/ml), DBA-ob/ob mice maintain their increased adiposity and have a large increase in beta-cell number. In mice with low insulin (<1 ng/ml) DBA-ob/ob mice have greatly diminished adiposity. These mice have atrophied islets with evidence of increased beta-cell neogenesis from the ductal epithelium. CONCLUSIONS: The strain-specific responses suggest the existence of genetic variants that control insulin sensitivity and beta-cell responses in the strains described in this report. These new models of obesity-diabetes should prove useful in dissecting the genetic control of beta-cell responses to hyperglycaemia and insulin resistance.
AIMS: Our goal was to identify genetic variants that determine the response to insulin resistance and hyperglycaemia. This report documents the diabetes syndrome of two new congenic strains of mice generated by the transfer of the Lepr(db) mutation to the FVB/NJ strain and the Lep(ob) mutation to the DBA/2J strain. METHODS:Mice were characterised by measures of blood metabolites and hormones along with challenges with glucose and insulin injections. Histological examinations of the endocrine pancreas and the kidneys were also carried out. RESULTS:Obesemice of the FVB-db congenic strain show long-term hyperglycaemia that is primarily due to severe insulin resistance. The hyperglycaemia in the fed state persists despite escalating secretion of insulin and massive increase of pancreatic beta cells. Obese FVB-db mice show evidence of mesangial matrix expansion, a hallmark of diabetic nephropathy. Leptin-deficient mice of the DBA-ob strain have variable obesity-diabetes. In mice with high insulin (>10 ng/ml), DBA-ob/ob mice maintain their increased adiposity and have a large increase in beta-cell number. In mice with low insulin (<1 ng/ml) DBA-ob/ob mice have greatly diminished adiposity. These mice have atrophied islets with evidence of increased beta-cell neogenesis from the ductal epithelium. CONCLUSIONS: The strain-specific responses suggest the existence of genetic variants that control insulin sensitivity and beta-cell responses in the strains described in this report. These new models of obesity-diabetes should prove useful in dissecting the genetic control of beta-cell responses to hyperglycaemia and insulin resistance.
Authors: Streamson Chua; Yifu Li; Shun Mei Liu; Ruijie Liu; Ka Tak Chan; Jeremiah Martino; Zongyu Zheng; Katalin Susztak; Vivette D D'Agati; Ali G Gharavi Journal: Kidney Int Date: 2010-06-02 Impact factor: 10.612
Authors: Michael S Hu; Graham G Walmsley; Leandra A Barnes; Kipp Weiskopf; Robert C Rennert; Dominik Duscher; Michael Januszyk; Zeshaan N Maan; Wan Xing Hong; Alexander Tm Cheung; Tripp Leavitt; Clement D Marshall; Ryan C Ransom; Samir Malhotra; Alessandra L Moore; Jayakumar Rajadas; H Peter Lorenz; Irving L Weissman; Geoffrey C Gurtner; Michael T Longaker Journal: JCI Insight Date: 2017-10-05
Authors: Alethia Villasenor; Zhao V Wang; Lee B Rivera; Ozhan Ocal; Ingrid Wernstedt Asterholm; Philipp E Scherer; Rolf A Brekken; Ondine Cleaver; Thomas M Wilkie Journal: Dis Model Mech Date: 2010-07-08 Impact factor: 5.758
Authors: Robert S Garofalo; Stephen J Orena; Kristina Rafidi; Anthony J Torchia; Jeffrey L Stock; Audrey L Hildebrandt; Timothy Coskran; Shawn C Black; Dominique J Brees; Joan R Wicks; John D McNeish; Kevin G Coleman Journal: J Clin Invest Date: 2003-07-03 Impact factor: 14.808
Authors: Esther van de Wall; Rebecca Leshan; Allison W Xu; Nina Balthasar; Roberto Coppari; Shun Mei Liu; Young Hwan Jo; Robert G MacKenzie; David B Allison; Nae J Dun; Joel Elmquist; Bradford B Lowell; Gregory S Barsh; Carl de Luca; Martin G Myers; Gary J Schwartz; Streamson C Chua Journal: Endocrinology Date: 2007-12-27 Impact factor: 4.736